By Pharmicell Lab Moisturzing Face Toning Mist_120ml
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- Category
- Face Mask
Pharmicell Co., Ltd.
South Korea
- Verified Certificate
-
12
| Product name | By Pharmicell Lab Moisturzing Face Toning Mist_120ml | Certification | - |
|---|---|---|---|
| Category | Face Mask | Ingredients | - |
| Keyword | - | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | Stock | - | |
| Supply type | - | HS code | - |
Product Information
Moisture mist that effectively hydrates your skin, like long awaited rain By Pharmicell Lab Moisturizing Face Toning Mist 120ml
Product introduction
| By Phrmicell Lab Moisturizing Face Toning Mist_120ml |
Containing1% of liposome extract of human bone marrow stem cell conditioned media / contains 70% glacial water
Moisturizing Face Toning Mist replenishes your skin's natural moisture that is easy to be lost in daily life, and it helps revitalize your fatigued skin due to a noxious environment, It is moisture mist with multi functions, designed to be easily portable and simply used anytime, anywhere.
Main Ingredients
- Human bone marrow stem cell conditioned media 1% purslane extract, ginseng extract, tea tree leaf oil, rosemary leaf oil, maitake extract and glacial water
How to use
- Before applying make-up, spray the product onto your face in dry indoor, at a distance of 10cm away from your face. Use it as often as needed.
- This is based on the compressed spraying method and you do not need to shake the product prior to it's use.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Hyeonsoo Kim
- Address
- 12F, Chungho-B/D, 3-2, Nonhyeon-dong, Gangnam-gu, Seoul, Korea
- Product Category
- Makeup Brushes
- No. of Total Employees
- 101-500
- Company introduction
-
Pharmicell is devoting itself to the development and commercialization if stem cell therapeutics for the conquest of incurable diseases such as cancer, brain and nervous system disorders, heart diseases that are the most fatal to human beings. Pharmicell is planning to accelerate the development of stem cell therapeutics for acute ischemic stroke(IND-phase 3)and chronic spinal cord injury(IND-phase 2/3)with the experiences relating to the NDA approval of stem cell therapeutics for acute myocardial infarction. In addition, we will continuously launch stem cell therapeutics according to our new drug development pipeline to treat alcoholic cirrhosis, pulmonary fibrosis, and cancer under investigator?s trials and thereby give hope to the patients who are suffering from these incurable diseases. Moreover, we will contribute to the vitalization of the industry related to stem cells through commercialization of stem cell therapeutics, stem cell banking, cell media, CMO(contract Manufacturing Organization), stem cell culturing media, cell processing equipment, cell transport box, manufacturing and quality control software by utilizing our know-how accumulated in the process of commercialization of stem cell therapeutics. This company has secured the intellectual property rights through the registration of patent for stem cell differentiation technology(dendritic cell production technology for anticancer immune treatment and production technology of nerve cells for treatment of brain and nervous system disorders) in foreign countries(7 countries including the US and EU) in order to gain technological competitive edge in the global markets.
- Main Product
_2.png "Frudia Royal de Ginseng Red Mask _10pcs__1")
